We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AGENCIES TO PEN NEW LABELING RULES FOR SCHEDULE II DRUGS
AGENCIES TO PEN NEW LABELING RULES FOR SCHEDULE II DRUGS
March 5, 2004
As part of the Bush administration’s effort to curb widespread abuse of prescription painkillers, the FDA and the Drug Enforcement Administration (DEA) are developing new, more explicit labeling guidelines for manufacturers of controlled substances like Purdue Pharma’s OxyContin and Abbott Laboratories’ Vicodin.